NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Chlorhydrate of Ropivacaine and Breast Cancer Surgery

CompletedPhase 4

Sponsor: Institut Curie

Conditions: Breast Neoplasms, Pain,Postoperative

Interventions: Chlorhydrate de Ropivacaine, placebo

Countries: France

The aim of the study is to evaluate the effect of local anesthetic (chlorhydrate of ropivacaine) to prevent chronic pain after breast surgery for cancer.

Eligibility overview

Sex: FEMALE

Age: 18 Years to 85 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Breast cancer patients treated by conservative surgery with axillary node dissection or treated by mastectomy with or without axillary node dissection or sentinel lymph node biopsy.
* ASA physical status 1, 2 or 3
* With a minimum life expectancy of 2 years
* Written informed consent

Exclusion Criteria:

* Any previous cancer other than breast cancer
* Allergies to local anesthesic and morphine
* Reported history of drug
* Pregnancy
* Homolateral breast surgery during the last 3 years
* Analgesic use pre-operatively
* Renal, pulmonary or liver major dysfunction
* Active malignant disease
* Unable to follow the protocol for any reason

Locations (1)

Saint-Cloud, France